Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cancer genomics of urothelial cancer and fibroepithelial tumors of the breast

Prof Bin Tean Teh - National Singapore Cancer Center, Singapore
Cancer genomics of urothelial cancer and fibroepithelial tumors of the breast ( Prof Bin Tean Teh - National Singapore Cancer Center, Singapore )
3 Jul 2015

Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL

Dr Paula Cramer - University of Cologne, Köln, Germany
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL ( Dr Paula Cramer - University of Cologne, Köln, Germany )
30 Jun 2015

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015

Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )
17 Jun 2015

EHA 2015 highlights

Peter Goodwin - ecancer reporter
EHA 2015 highlights ( Peter Goodwin - ecancer reporter )
17 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK
Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
16 Jun 2015

Are CML patients being treated to the correct standard?

Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany
Are CML patients being treated to the correct standard? ( Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany )
16 Jun 2015

Exciting new developments in proton therapy treatments

Dr Hernán Cortés-Funes - HC Marbella, Marbella, Spain
Exciting new developments in proton therapy treatments ( Dr Hernán Cortés-Funes - HC Marbella, Marbella, Spain )
16 Jun 2015

PDL1 expression in thymic tumours

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
PDL1 expression in thymic tumours ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
16 Jun 2015

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
15 Jun 2015

EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM

Prof John Gribben, Prof Marivi Mateos, Prof Umberto Vitolo, Prof Paolo Ghia
EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM ( Prof John Gribben, Prof Marivi Mateos, Prof Umberto Vitolo, Prof Paolo Ghia )
14 Jun 2015